A new clinical trial, led by Professor John Bridgewater (UCL Cancer Institute) and UCLH, aims to extend survival for some patients with cancer in the biliary tract by treating them with therapies specifically tailored to the genetic profile of their tumour.
Read: Standard, More: Sun, UCL News
Close
